Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 1, 2006, Pages 28-35

  Avci, Remzi ^a   Kaderli, Berkant ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Chronic diabetic macular oedema; Hard exudates; Intravitreal triamcinolone injection

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOCULAR HYPERTENSION; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA EXUDATE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; VISUAL ACUITY;

ADULT; AGED; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 29544434880     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0069-5     Document Type: Article

References (20)

1. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr (2002) Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80:667-777 10.1046/j.0022-3042.2001.00740.x
2. Bakri SJ, Beer PM (2004) Intravitreal triamcinolone injection for diabetic macular edema: A clinical and fluorescein angiographic case series. Can J Ophthalmol 39:755-760 15696765
3. Bresnick GH (1983) Diabetic maculopathy: A critical review highlighting diffuse macular edema. Ophthalmology 90:1301-1317 6664669
4. Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: An optical coherence tomography study. Br J Ophthalmol 88:1131-1136 10.1136/bjo.2004.041707
5. Fisher S, Renz D, Schaper W, Karliczek GF (2001) In vitro effects of dexamethasone on hypoxia-induced permeability and expression of vascular endothelial growth factor. Eur J Pharmacol 411:231-243 10.1016/ S0014-2999(00)00915-8
6. Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD (1997) Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 115:873-877 9230827
7. Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I (2004) Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 138:158-160 10.1016/j.ajo.2004.02.025
8. Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61 10.1001/archopht.121.5.729
9. Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425-427 10.1016/S0002-9394(01)01010-8
10. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 91:1464-1474 6521986
11. Levine RM, Rasmussen JE (1983) Intralesional corticosteroids in the treatment of nodulocystic acne. Arch Dermatol 119:480-481 10.1001/ archderm.119.6.480
12. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927 10.1016/S0161-6420(02)00975-2
13. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial. Ophthalmology 111:218-224 10.1016/j.ophtha.2003.05.037
14. Mohan K, Dhir SP, Munjal VP, Jain IS (1986) The use of intralesional steroids in the treatment of chalazion. Ann Ophthalmol 18:158-160 3592474
15. Otani T, Kishi S (2001) Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol 131:50-54 10.1016/ S0002-9394(00)00661-9
16. Ozkiris A, Evereklioglu C, Erkilic K, Tamcelik N, Mirza E (2004) Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 14:543-549 15638105
17. Sakuraba T, Suzuki Y, Mizutani H, Nakazawa M (2000) Visual improvement after removal of submacular exudates in patients with diabetic maculopathy. Ophthalmic Surg Lasers 31:287-291 10928665
18. Takagi H, Otani A, Kiryu J, Ogura Y (1999) New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology 106:249-256 10.1016/S0161-6420(99)90054-4
19. Takaya K, Suzuki Y, Mizutani H, Sakuraba T, Nakazawa M (2004) Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina 24:23-29 10.1097/ 00006982-200402000-00004
20. Yang CM (2000) Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 20:121-125 10.1097/00006982-200003000-00002